Navigation Links
Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

red at doses as low as one twentieth of the recommended human dose of REBETOL. If pregnancy occurs in a patient or partner of a patient during treatment or during the 6 months after treatment stops, physicians are encouraged to report such cases by calling (800) 727-7064.

There are no new adverse events specific to PEGINTRON as compared to INTRON(R) A (Interferon alfa-2b, recombinant) for Injection; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. The most common adverse events associated with PEGINTRON were "flu- like" symptoms, occurring in approximately 50 percent of patients, which may decrease in severity as treatment continues. Application site disorders were common (47 percent), but all were mild (44 percent) or moderate (4 percent) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2 percent of patients receiving PEGINTRON. Alopecia (thinning of the hair) is also often associated with alpha interferons including PEGINTRON.

Psychiatric adverse events, which include insomnia, were common (57 percent) with PEGINTRON but similar to INTRON A (58 percent). Depression was most common at 29 percent. Suicidal behavior including ideation, suicidal attempts, and completed suicides occurred in 1 percent of patients during or shortly after completing treatment with PEGINTRON.

PEGINTRON/REBETOL is contraindicated in patients with autoimmune hepatitis, decompensated liver disease, and in patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia).

The following serious or clinically significant adverse events have been reported at a frequency less than 1 percent with PEGINTRON or interferon alpha: severe decreases in neutrophil or platelet counts, hypothyroidism, hyperglycemia, hypotension, arrhythmia, ulcerative and hemorrhagic colitis, development or exacerbation of aut
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
2. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
3. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
7. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
8. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
9. Major Manufacturer of Unapproved and Adulterated Drugs
10. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:3/31/2015)... , March 31, 2015 ... "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA ... Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global ... Life Science and Chemical Instrumentation Market is expected ... of 6.9% from 2014 to 2019. ...
(Date:3/31/2015)... March 31, 2015  SCILEX Pharmaceuticals, Inc., a company ... on the treatment of pain, today announced that ITOCHU ... ), a member of ITOCHU Corporation ( Tokyo ... leading sogo shosha (general trading companies) in ... SCILEX.  ICF has worked closely with SCILEX as an ...
(Date:3/31/2015)... -- Ariana Smith, a 17-year-old Taylor teen, became the first patient ... a part of the Detroit Medical Center (DMC), and the ... a revolutionary 3D printed heart model to aid heart specialists ... In November, 2014, Ariana,s mom Jacqueline Foster ... a test that checks for problems with the electrical activity ...
Breaking Medicine Technology:Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 2Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 3Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 4Taylor Teen Becomes First Patient in Michigan to Benefit From 3D Printed Heart Model to Treat Life-Threatening Aneurysm 5
(Date:3/31/2015)... Companies in the Benefit ... maintaining and managing their employees' benefits. These benefits ... to individual retirement accounts, maternity leave, vacation time ... administration of workers' compensation for companies that opt ... on conditions in the labor market and companies' ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 RE/MAX agents ... 2014 for Children’s Miracle Network Hospitals® – most of ... the RE/MAX Miracle Home and Miracle Property programs, offices ... to provide ongoing support to their local children’s hospitals, ... , Since partnering with Children’s Miracle Network Hospitals ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 St. Joseph ... growing network of leading healthcare systems, major physician groups ... information for the benefit of patients. The health information ... that supports well coordinated care throughout the continuum of ... a long tradition of providing services to a broad ...
(Date:3/31/2015)... Chicago, Illinois (PRWEB) March 31, 2015 ... NetZoom Visio Stencils Device Library for documenting and ... the following Visio Stencils: , Manufacturer / ... Dell PowerEdge r720, Dell PowerEdge r520, Dell PowerEdge ... IBM Power 8 Series, EMC VMAX 100K, VMAX ...
(Date:3/31/2015)... Indiana (PRWEB) March 31, 2015 ... DeRose in Youngstown, Ohio in 1987. This ... the curve with not just customer satisfaction, but ... been added to the well-stocked arsenal of Yesco ... by American Green Technology® (AGT). The patented environmental ...
Breaking Medicine News(10 mins):Health News:Benefit Administration Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Benefit Administration Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 2Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 3Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:American Green Technology® Signs Exclusive Agreement to Distribute Health Risk Management System in Midwest 2
... March 26 Two Miami-area residents pleaded guilty today ... involving HIV infusion clinics, Acting Assistant Attorney General Rita ... R. Alexander Acosta of the Southern District of Florida ... 44, each pleaded guilty to one count of conspiracy ...
... Abusing real-time communication tools like instant messenger, texts ... reps to engage with physicians."A lot of people at ... stated a sales executive in a roundtable discussion conducted ... they,re so distracted by doing four things at once ...
... team effort between personnel at Graham Packaging,s Chalgrove plant ... California-based Life Technologies, was key in helping to develop ... bottle that Graham Packaging produces for Invitrogen is a ... the efficiency of storage and the ease of use. ...
... Stress cardiomyopathy linked to common drugs, study finds , , ... syndrome called stress cardiomyopathy can be triggered by some ... , Nine cases of the condition followed injections of ... March 25 online issue of the Journal ...
... InSight,s RCM CapabilitiesPLANO, Texas and LAKE FOREST, Calif., March ... (OTC Bulletin Board: ISGT) ("InSight") has, through ... Systems Corporation (NYSE: PER ) ( www.perotsystems.com ... of upgraded technology and IT services. Perot Systems ...
... Community to Drive Innovation through Investment Opportunities in the ... The 510(k) program is under siege from within and ... a letter to Congress that CDRH management is overruling ... They followed that complaint to Congress with another letter ...
Cached Medicine News:Health News:Miami Doctor and Chemist Plead Guilty in HIV Infusion Fraud Scheme 2Health News:Miami Doctor and Chemist Plead Guilty in HIV Infusion Fraud Scheme 3Health News:Sales Force Effectiveness: Less Texting, More Engagement 2Health News:Graham Packaging's Teamwork with Invitrogen Leads to an Award-Winning New Medical Container 2Health News:What Causes Mystery Heart Condition? 2Health News:What Causes Mystery Heart Condition? 3Health News:InSight Health Services Holdings Corp. and Perot Systems Corporation Announce Seven-Year Revenue Cycle Management Agreement 2Health News:InSight Health Services Holdings Corp. and Perot Systems Corporation Announce Seven-Year Revenue Cycle Management Agreement 3Health News:InSight Health Services Holdings Corp. and Perot Systems Corporation Announce Seven-Year Revenue Cycle Management Agreement 4Health News:FDA Fireside Chat @ The 8th Annual MedTech Investing Conference May 6-7, 2009 2Health News:FDA Fireside Chat @ The 8th Annual MedTech Investing Conference May 6-7, 2009 3Health News:FDA Fireside Chat @ The 8th Annual MedTech Investing Conference May 6-7, 2009 4
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... ASRs* are specifically designed for PCR ... two-color fluorescence detection systems. The NGEN ... detection of mutations associated with cystic ... well as reagents for the detection ...
... MGB Alert Detection Reagents provide molecular ... PCR based assays. By using our MGB ... analysis, Nanogen is now able to provide ... nucleic acid sequences of specific organisms or ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
Medicine Products: